{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:53:44Z","timestamp":1761893624207,"version":"build-2065373602"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1999,6,1]],"date-time":"1999-06-01T00:00:00Z","timestamp":928195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1999,6,1]],"date-time":"1999-06-01T00:00:00Z","timestamp":928195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[1999,6]]},"DOI":"10.1054\/ghir.1999.0102","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T10:55:42Z","timestamp":1032432942000},"page":"165-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy"],"prefix":"10.1054","volume":"9","author":[{"given":"D.N.","family":"O\u2019Neal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.L.","family":"Hew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.D.","family":"Best","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Alford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1054\/ghir.1999.0102_RF1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0163-7827(81)90067-9","article-title":"Role of lipids and lipoprotein fractions in assessing atherogenesis","volume":"20","author":"Kannell","year":"1981","journal-title":"The Framingham Study. Prog Lipid Res"},{"key":"10.1054\/ghir.1999.0102_RF2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","article-title":"Premature mortality due to cardiovascular disease in hypopituitarism","volume":"336","author":"Rosen","year":"1990","journal-title":"Lancet"},{"key":"10.1054\/ghir.1999.0102_RF3","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/0140-6736(92)92892-J","article-title":"Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults","volume":"340","author":"Markussis","year":"1992","journal-title":"Lancet"},{"key":"10.1054\/ghir.1999.0102_RF4","first-page":"2448","article-title":"Low density lipoprotein particle size in hypopituitary adults receiving conventional hormone replacement therapy","volume":"81","author":"O\u2019Neal","year":"1996","journal-title":"J Clin End Metab"},{"key":"10.1054\/ghir.1999.0102_RF5","first-page":"195","article-title":"Cardiovascular risk factors in adult patients with growth hormone deficiency","volume":"129","author":"Rosen","year":"1993","journal-title":"Acta Endo."},{"key":"10.1054\/ghir.1999.0102_RF6","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/0026-0495(93)90145-E","article-title":"Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency","volume":"42","author":"Cuneo","year":"1993","journal-title":"Metabolism"},{"key":"10.1054\/ghir.1999.0102_RF7","first-page":"173","article-title":"Metabolic abnormalities in growth hormone-deficient adults","volume":"1","author":"Beshyah","year":"1994","journal-title":"II. Carbohydrate tolerance and lipid metabolism. Endocrinol Metab"},{"key":"10.1054\/ghir.1999.0102_RF8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0026-0495(94)90245-3","article-title":"Serum lipid levels in growth hormone-deficient men","volume":"43","author":"de Boer","year":"1994","journal-title":"Metabolism"},{"key":"10.1054\/ghir.1999.0102_RF9","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.ATV.14.3.434","article-title":"High fibrinogen and plasminogen activator inhibitor activity in growth hormone deficient adults","volume":"14","author":"Johansson","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1054\/ghir.1999.0102_RF10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00005792-199001000-00004","article-title":"Long term follow-up of hypopituitary patients treated with human growth hormone","volume":"69","author":"Libber","year":"1990","journal-title":"Medicine"},{"key":"10.1054\/ghir.1999.0102_RF11","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/01.CIR.61.2.302","article-title":"Lipoprotein cholesterol distributions in selected North American populations: the Lipid Research Clinics Program Prevalence Study","volume":"61","author":"Heiss","year":"1980","journal-title":"Circulation"},{"key":"10.1054\/ghir.1999.0102_RF12","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1001\/jama.1988.03410130125037","article-title":"Low density lipoprotein subclass patterns and risk of myocardial infarction","volume":"260","author":"Austin","year":"1988","journal-title":"JAMA"},{"key":"10.1054\/ghir.1999.0102_RF13","first-page":"2653","article-title":"Fasting and Postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy","volume":"82","author":"Al-Shoumer","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.1999.0102_RF14","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/ajcn\/61.6.1290","article-title":"Adipose tissue assessed by magnetic resonance imaging in growth hormone-deficient adults: the effect of growth hormone replacement and a comparison with control subjects","volume":"61","author":"Snel","year":"1995","journal-title":"Am J Clin Nutrition"},{"key":"10.1054\/ghir.1999.0102_RF15","first-page":"975","article-title":"The effect of 3 months of recombinant human growth hormone (GH) therapy on insulin and glucose mediated glucose disposal and insulin secretion in GH-deficient adults: a minimal model analysis","volume":"79","author":"O\u2019Neal","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.1999.0102_RF16","first-page":"93","article-title":"Insulin tolerance test in patients with anterior pituitary hormone deficiency: reduced insulin sensitivity","volume":"2","author":"Hew","year":"1995","journal-title":"Endcrinol Metab"},{"key":"10.1054\/ghir.1999.0102_RF17","first-page":"555","article-title":"Insulin resistance in growth hormone-deficient adults: defects in glucose utilisation and glycogen synthase activity","volume":"81","author":"Hew","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.1999.0102_RF18","first-page":"77","volume":"8 (Suppl. A)","year":"1998","journal-title":"Untreated growth hormone deficiency explains premature mortality in patients with hypopituitarism. Growth Hormone IGF Res"},{"key":"10.1054\/ghir.1999.0102_RF19","first-page":"1181","article-title":"Defects of insulin action and skeletal muscle glucose disposal in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy","volume":"83","author":"Christopher","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.1999.0102_RF20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultra-centrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1054\/ghir.1999.0102_RF21","series-title":"Methods in Enzymology. Chap 8","doi-asserted-by":"crossref","DOI":"10.1016\/0076-6879(86)28068-4","article-title":"Single vertical spin density gradient ultracentrifugation","author":"Chung","year":"1986"},{"key":"10.1054\/ghir.1999.0102_RF22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0022-2275(20)38178-5","article-title":"Identification of multiple classes of low density lipoproteins in normal humans","volume":"23","author":"Krauss","year":"1982","journal-title":"J Lipid Res"},{"key":"10.1054\/ghir.1999.0102_RF23","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0272-6386(96)90034-7","article-title":"Low-density lipoprotein particles size distribution in end-stage renal disease treated with hemodialysis or peritoneal dialysis","volume":"27","author":"O\u2019Neal","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1054\/ghir.1999.0102_RF24","first-page":"487","article-title":"A sensitive precise radioimmunoassay of serum insulin based on a charcoal separation of bound and free hormone moieties","volume":"70","author":"Albano","year":"1972","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1054\/ghir.1999.0102_RF25","first-page":"187","article-title":"Recent advances in glycosylated hemoglobin measurements","volume":"21","author":"Goldstein","year":"1984","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1054\/ghir.1999.0102_RF26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/219193b0","article-title":"Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone","volume":"219","author":"Orskov","year":"1968","journal-title":"Nature"},{"key":"10.1054\/ghir.1999.0102_RF27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/000456328602300406","article-title":"The measurement of insulin-like growth factor-I: clinical applications and significance","volume":"23","author":"Teale","year":"1986","journal-title":"Ann Clin Biochem"},{"key":"10.1054\/ghir.1999.0102_RF28","first-page":"45","article-title":"Measurement of abdominal and intra-abdominal fat in post menopausal women by dual energy X-ray absorptiometry and anthropometry: comparison with computerised tomography","volume":"17","author":"Svendsen","year":"1993","journal-title":"Int J Obesity"},{"key":"10.1054\/ghir.1999.0102_RF29","first-page":"633","article-title":"Abdominal fat and insulin resistance in normal and overweight women","volume":"45","author":"Carey","year":"1996","journal-title":"Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes"},{"key":"10.1054\/ghir.1999.0102_RF30","first-page":"55","article-title":"Effects of growth hormone deficiency and replacement in adults on skeletal muscle glucose metabolism, lipid profiles and regional body composition","volume":"3 (Suppl. A)","author":"Hew","year":"1996","journal-title":"Endocrinol Metab"},{"key":"10.1054\/ghir.1999.0102_RF31","first-page":"305","article-title":"Long-term cardiovascular effects of growth hormone treatment in GH-deficient adults","volume":"45","author":"Johannsson","year":"1996","journal-title":"Preliminary data in a small group of patients. Clin Endocrinol"},{"key":"10.1054\/ghir.1999.0102_RF32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0021-9150(97)00110-X","article-title":"The effect of growth hormone replacement therapy for up to 12 months on lipoprotein composition and lipoprotein (a) in growth hormone-deficient adults","volume":"133","author":"Webster","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1054\/ghir.1999.0102_RF33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2265.1992.tb02287.x","article-title":"The effect of growth hormone administration in growth hormone deficient adults on bone, protein carbohydrate and lipid homeostasis, as well as on body composition","volume":"37","author":"Binnerts","year":"1992","journal-title":"Clin Endocrinol"},{"key":"10.1054\/ghir.1999.0102_RF34","first-page":"2142","article-title":"Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficient adults","volume":"15","author":"Johannsson","year":"1995","journal-title":"Influence of gender and apo [a] and Apo E phenotypes. Arterioscler Thromb Vasc Biol"},{"key":"10.1054\/ghir.1999.0102_RF35","first-page":"356","article-title":"The effects of short and long term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance","volume":"80","author":"Beshyah","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.1999.0102_RF36","first-page":"153","article-title":"The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults","volume":"80","author":"Weaver","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.1999.0102_RF37","first-page":"51","article-title":"An open 36-month study of lipid changes with growth hormone in adults: lipid changes following replacement of growth hormonein adult acquired growth hormone deficiency","volume":"134","author":"Garry","year":"1993","journal-title":"Eur J Endocrinol"},{"key":"10.1054\/ghir.1999.0102_RF38","first-page":"550","article-title":"Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women","volume":"82","author":"Burman","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.1999.0102_RF39","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1210\/endo.136.9.7649083","article-title":"Growth hormone specifically stimulates the expression of low density lipoprotein in human hepatoma cells","volume":"136","author":"Parni","year":"1995","journal-title":"Endocrinology"},{"key":"10.1054\/ghir.1999.0102_RF40","first-page":"292","article-title":"Regulation of rat low density lipoprotein receptors","volume":"97","author":"Rudling","year":"1996","journal-title":"In vivo"},{"key":"10.1054\/ghir.1999.0102_RF41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1096-6374(98)80022-1","article-title":"The use of growth hormone in adults: a review of the last 10 years, the present and a perspective for the future","volume":"8","author":"Bengtsson","year":"1998","journal-title":"Growth Hormone IGF Res"},{"key":"10.1054\/ghir.1999.0102_RF42","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/01.ATV.13.2.296","article-title":"Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp[a] and HDL cholesterol concentrations","volume":"13","author":"Eden","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"10.1054\/ghir.1999.0102_RF43","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1210\/jcem-64-4-723","article-title":"Relationships of plasma estradiol, testosterone and sex hormone binding globulin with lipoproteins, apolipoproteins, and high density lipoprotein subfractions in men","volume":"64","author":"Stefanick","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.1999.0102_RF44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0140-6736(79)90001-1","article-title":"Altered plasma lipid and lipoprotein levels associated with oral contraceptive and oestrogen use","volume":"2","author":"Wallace","year":"1979","journal-title":"Lancet"},{"key":"10.1054\/ghir.1999.0102_RF45","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM198912283212605","article-title":"The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency","volume":"321","author":"Salomen","year":"1989","journal-title":"N Eng J Med"},{"key":"10.1054\/ghir.1999.0102_RF46","first-page":"147","article-title":"Assessment of regional body composition by dual energy X-Ray absorptiometry in hypopituitary adults before and during growth hormone treatment","volume":"2","author":"Beshyah","year":"1995","journal-title":"Endocrinol Metab"},{"key":"10.1054\/ghir.1999.0102_RF47","first-page":"309","article-title":"Treatment of adults with growth hormone (GH) deficiency with recombinant human GH","volume":"76","author":"Bengtsson","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1054\/ghir.1999.0102_RF48","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1172\/JCI116541","article-title":"Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles","volume":"92","author":"Reaven","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1054\/ghir.1999.0102_RF49","first-page":"E211","article-title":"growth hormone treatment of obese women for 5 wk: effect on body composition and adipose tissue LPL activity","volume":"266","author":"Richelsen","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1054\/ghir.1999.0102_RF50","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1126\/science.2530631","article-title":"The mysteries of lipoprotein [a]","volume":"246","author":"Utermann","year":"1989","journal-title":"Science"},{"key":"10.1054\/ghir.1999.0102_RF51","first-page":"51","article-title":"Lp[a] lipoprotein as arisk factor for coronary heart disease and cerebral infarction","volume":"38","author":"Murai","year":"1981","journal-title":"Atherosclerosis"},{"key":"10.1054\/ghir.1999.0102_RF52","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/000456329603300408","article-title":"Increased derum lipoprotein [a] concentrations after growth hormone (GH) treatment in patients with isolated GH deficiency","volume":"33","author":"O\u2019Halloran","year":"1996","journal-title":"Ann Clin Biochem"},{"key":"10.1054\/ghir.1999.0102_RF53","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1530\/eje.0.1360377","article-title":"Growth hormone increases and insulin-like growth factor-I decreases circulating lipoprotein [a]","volume":"136","author":"Laron","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"10.1054\/ghir.1999.0102_RF54","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2265.1995.tb02699.x","article-title":"Recombinant human insulin-like growth factor-I decreases serum lipoprotein [a] concentrations in normal adult men","volume":"42","author":"Oscarsson","year":"1995","journal-title":"Clin Endocrinol"}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637499901028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637499901028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:38:49Z","timestamp":1761086329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637499901028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,6]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,6]]}},"alternative-id":["S1096637499901028"],"URL":"https:\/\/doi.org\/10.1054\/ghir.1999.0102","relation":{},"ISSN":["1096-6374"],"issn-type":[{"type":"print","value":"1096-6374"}],"subject":[],"published":{"date-parts":[[1999,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1054\/ghir.1999.0102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1999 Harcourt Publishers Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}